Recent Patents on Inflammation & Allergy Drug Discovery
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 1
Author(s): Kam-Lun Ellis Hon
Affiliation:
Export Options
About this article
Cite this article as:
Hon Ellis Kam-Lun, Meet Our Editorial Board Member, Recent Patents on Inflammation & Allergy Drug Discovery 2020; 14 (1) . https://dx.doi.org/10.2174/1872213X1401200309093832
DOI https://dx.doi.org/10.2174/1872213X1401200309093832 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
2
Related Articles
-
Phenylbutyric Acid: Simple Structure - Multiple Effects
Current Pharmaceutical Design Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis
Current Medicinal Chemistry Review of Endocrine Manifestations of Antiphospholid Syndrome
Current Rheumatology Reviews Editorial [Hot Topic: Neuron-Glia Interaction (Guest Editor: Joao O. Malva)]
Current Drug Targets - CNS & Neurological Disorders Development and Chemistry of Histamine H4 Receptor Ligands as Potential Modulators of Inflammatory and Allergic Responses
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Integrin Function and Signaling as Pharmacological Targets in Cardiovascular Diseases and in Cancer
Current Pharmaceutical Design Editorial (Thematic Issue: Myokines and Exercise Training: More Shadows than Lights)
Current Pharmaceutical Design In Search of the Most Suitable Lentiviral shRNA System
Current Gene Therapy Micropropagation: A Tool for the Production of High Quality Plant-based Medicines
Current Pharmaceutical Biotechnology Predicting Pediatric Drug Disposition-Present and Future Directions of Pediatric Physiologically-Based Pharmacokinetics
Drug Metabolism Letters Reactive Oxygen Species as Intracellular Signaling Molecules in the Cardiovascular System
Current Cardiology Reviews Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents
Mini-Reviews in Medicinal Chemistry COX-2 Inhibition Versus Gastroprotection with Dual COX Inhibitors: An Evidence-Based Approach
Current Pharmaceutical Design Deciphering Transcriptional Regulation Relevant to Eating Behavior
Current Genomics Novel Nano Drug Systems for Cardiovascular Applications
Recent Patents on Biomedical Engineering (Discontinued) The Many Facets of Cell Injury: Angiogenesis to Autophagy
Current Neurovascular Research Theoretical Studies on Pentadienyl Cation Electrocyclizations
Current Organic Chemistry Hypersensitivity Reactions to Last Generation Chimeric, Umanized and Human Recombinant Monoclonal Antibodies for Therapeutic Use
Current Pharmaceutical Design Hsp70 in Oncology
Recent Patents on DNA & Gene Sequences